25 May 2013
Keywords: Genzyme, ChemRar, Russia, Orpohan drug, Rare diseases, Vaccines, R&D
Article | 28 March 2011
US biotech Genzyme (Nasdaq: GENZ), the subject of a takeover by French drug major Sanofi-Aventis, has signed an agreement with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 March 2011
29 March 2011
24 May 2013
© 2013 thepharmaletter.com